Multi-strategy hedge funds, composed of lots of individual portfolio managers, have seen assets under management boom in recent years, thanks to astonishingly consistent returns throughout the cycle. If you're one of the PMs, the money can be incredibly lucrative. But job security is fickle, and it's easy to lose your place on the team. So how do you actually get your seat and keep it? On this episode, we speak with Brian Yelvington, a consultant at the recruitment firm Carrington Fox. He's also a longtime veteran of the industry, having been a trader at many large firms. He discusses how people get their foot in the door, the skills needed to succeed, and how to think about optimizing returns while avoiding ruin.

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

What do young professionals in New York City actually think about money and capitalism? According to our guest Emily Sundberg, creator of the Feed Me newsletter, there is a foreboding sense that nobody is coming to save them. End times are coming. AI will take all the jobs. There's a limited time to "secure the bag." In this live episode, recorded in New York City in June, Emily talks about how this translates into consumption and investing decisions among today's youth, and how they see the world of politics.

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Every day we're inundated with headlines that are seemingly unbelievable. Multiple major wars are ongoing. Politics is erratic. Markets are scrambling everyone's brains. So how should we live and feel good? How should we think about the world around us, and the various perceived risks out there. In yet another episode from our live Odd Lots special in New York City last month, we speak with famed author Nassim Nicholas Taleb, the scientific advisor at Universa Investments, who shares his perspective on all things.

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Stocks plunged after the April 2 "Liberation Day," in one of the worst drawdowns in the market's history. Since then, however, we're basically back to all-time highs and things have been pretty calm in the market. On this episode, recorded live onstage at our June 26 event in New York, we speak to Nomura cross-asset strategist Charlie McElligott, about what's been driving the rally. He says he's seen "relentless" selling of volatility as investors who sold back in April chase the rally. That's culminated in some weird market dynamics. The question, of course, is how long this can continue and what it would take to unsettle things from here.

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

For awhile there was just MicroStrategy (which has since been renamed as Strategy.) It started buying Bitcoin, and then raised money to buy more Bitcoin, and the stock has done phenomenally well, despite the company not doing much else beside holding Bitcoin. But now it has spawned numerous copycats all doing the same thing. But the question is why? Why are people willing to buy shares of a company that owns Bitcoin, rather than just buying Bitcoin outright (which anyone can easily do now that there's an ETF)? On this episode of the podcast, recorded live in New York City, we speak with famed short-seller Jim Chanos about this phenomenon. We also talk about NYC real estate in the age of Zohran Mamdani, the latest at Tesla, private equity, and whether AI can replace people who understand accounting.

Read more:
Michael Saylor Shifts to Using Preferred Shares to Buy Bitcoin as Criticism Rises
Musk Confidant Afshar Leaves Tesla in Latest High-Level Exit

Only http://Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox each week, plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Think of a biotech company and most people will think of a business trying to come up with cures and treatments for human illnesses. There's not a lot of discussion about companies trying to do the same for animals, insects, or even... crustaceans. And yet, healthy animals are a key part of the ecosystem and important for our food supply. In this episode we speak to Annette Kleiser, CEO of Dalan Animal Health, which has developed the world's first vaccine for bees and is now working on a similar treatment to protect shrimp. We talk about the development and regulatory process, plus what it's actually like raising money for a brand new business.

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.